Combination of glucan, resveratrol and vitamin C demonstrates strong anti-tumor potential

Anticancer Research

Volumn 32, Issue 1, 2012, Pages 81-87

  Vetvicka, Vaclav ^a   Vetvickova, Jana ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cancer; Glucan; Immunity; Phagocytosis; Resveratrol; Vitamin C

Indexed keywords

ASCORBIC ACID; GLUCAN; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; FEMALE; LUNG TUMOR; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODY FORMATION; ANTIOXIDANTS; ASCORBIC ACID; BETA-GLUCANS; CARCINOMA, LEWIS LUNG; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTES; IMMUNOLOGIC FACTORS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; OVALBUMIN; PHAGOCYTOSIS; STILBENES;

EID: 84855704815     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Benacerraf B and Sebestyen MM: Effect of bacterial endotoxins on the reticuloendothelial system. Fed Proc 16: 860-867, 1957.
2. Chihara G, Maeda YY and Hamuro J: Current status and perspectives of immunomodulators of microbial origin. Int J Tis React IV: 207-225, 1982. (Pubitemid 13214957)
3. Vetvicka V, Thornton BP and Ross GD: Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 98: 50-61, 1996. (Pubitemid 26243820)
4. Ohno N, Egawa Y, Hashimoto T, Adachi Y and Yadomae T: Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol Pharm Bull 19: 608-612, 1996. (Pubitemid 26144620)
5. Clark AE, Kerrigan AM and Brown GD: β-Glucan receptors. In: Biology and Chemistry of Beta Glucan. Vetvicka V and Novak M (eds.). Bentham Science, pp. 19-38, 2011.
6. Kimura Y, Tojima H, Fukase S and Takeda K: Clinical evaluation of sizofilan asssistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol 511 (Suppl): 192-195, 1994. (Pubitemid 24104626)
7. Kogan G: (1-3,1-6)-β-D-Glucans of yeast and fungi and their biological activity, In: Studies in Natural Products Chemistry. Atta-ur-Rahman (ed.). Elsevier, Amsterdam, pp. 107-152, 2000.
8. Vetvicka V and Vetvickova J: Effects of yeast-derived beta-glucans on blood cholesterol and macrophage functionality. J Immunotoxicol 6: 30-35, 2009.
9. Novak M and Vetvicka V: Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol 5: 47-57, 2008. (Pubitemid 351431257)
10. Ditteova G, Velebny S and Hrckova G: Modulation of liver fibrosis and pathological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C. J Helmintol 77: 219-226, 2003.
11. Gao X, Xu XY, Janakiraman N, Chapman RA and Gautam SC: Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem Pharmacol 62: 1299-1308, 2001. (Pubitemid 33055634)
12. Losa GA: Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. Eur J Clin Invest 33: 818-823, 2003.
13. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farndworth NR, Kinghorn AD, Mehta RG, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997. (Pubitemid 127696281)
14. Do Amaral CL, Francescato HD, Coimbra TM, Costa RS, Darin JD, Antunes LM and Bianchi MD: Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. Arch Toxicol 82: 363-370, 2007.
15. Vetvicka V, Volny T, Saraswat-Ohri S, Vashishta A, Vancikova Z and Vetvickova J: Glucan and resveratrol complex - possible synergistic effects on immune system. Biomed Pap 151: 41-46, 2007.
16. Vetvicka V and Vancikova Z: Synergistic effects of glucan and resveratrol. A J Biochem Res 4: 105-110, 2010.
17. Kogan G, Sandula J, Korolenko, TA, Dalameeva, OV, Poteryaeva, ON, Zhanaeva, SY, Levina, OA, Filatova, TG and Kaledin, VI: Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator-yeast carboxymethyl glucan. Int Immunopharmacol 2: 775-781, 2002. (Pubitemid 34603122)
18. Vetvicka V, Fornusek L, Kopecek J, Kaminkova J, Kasparek L and Vranova M: Phagocytosis of human blood leukocytes: A simple micromethod. Immunol Lett 5: 97-100, 1982. (Pubitemid 13245894)
19. Vetvicka V and Yvin J-C: Effects of marine β-1,3 glucan on immune reactions. Int Immunopharmacol 4: 721-730, 2004. (Pubitemid 38595529)
20. Biology and Chemistry of Beta Glucan. Vetvicka V and Novak M (eds.). Bentham Science, 2011.
21. Yan J, Allendorf DJ and Brandley B: Yeast whole glucan particle (WGP) beta glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opin Biol Ther 5: 691-702, 2005. (Pubitemid 40780552)
22. Eicher SD, McKee CA, Carroll JA and Pajor EA: Supplemental vitamn C and yeast cell wall β-glucan as growth enhancers in newborn pigs and as immunomodulator after an endotoxin challenge after weaning. J Anim Sci 84: 2352-2360, 2006. (Pubitemid 44367859)
23. Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M and Ravagnan G: Effects of resveratrol on human immune cell function. Life Sci 70: 81-96, 2001. (Pubitemid 33124357)
24. Murkherjee S, Dudley JI and Das DK: Dose-dependency of resveratrol in providing health benefits. Dose-Response 8: 478-500, 2010.
25. Carr A and Frei B: Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13: 1007-1024, 1999. (Pubitemid 29249726)
26. Konno S: Synergistic potentiation of D-fraction with vitamin C as possible alternative approach to cancer therapy. Int J Gen Med 1: 91-108, 2009.
27. Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P and Yvin J-C: Orally administered (1-3)-β-D-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 40: 292-298, 2007.
28. Thornton BP, Vetvicka V, Pitman M, Goldman RC and Ross GD. β-Glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 156: 1235-1246, 1996.
29. Tsuzuki A, Tateishi T, Ohno N, Adachi Y and Yadomae T: Increase of hematopoietic responses by triple or single helical conformer of an antitumor beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice. Biosci Biotechnol Biochem 63: 104-110, 1999. (Pubitemid 129555244)
30. Ross GD, Thornton BP and Vetvicka V: Polysaccharide priming of CR3 (CD11b/CD18) allows NK cell killing of fresh breast tumor cells. The 9th Internat Cong Immunol 95: 1995.